Product Details
Jamp Amoxi Clav
Amoxicillin + Clavulanic Acid500 mg + 125 mg
Tablet
DIN/PIN/NPN
02508257
Manufacturer
Jamp Pharma Corporation
Formulary Listing Date
2022-02-28
Unit Price
0.3778
Amount MOH Pays
0.3778
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Amoxicillin + Clavulanic Acid: Amoxicillin/clavulanic acid is not recommended as first line treatment for acute otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.
ATC Code
J01CR02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02482576 | Sandoz Amoxi-Clav Tablets | 0.3778 | 0.3778 |
| 01916858 | Clavulin | 1.8875 | 0.3778 |
| 02243351 | Apo-Amoxi Clav | 0.3778 | 0.3778 |
| 02471698 | Auro-Amoxiclav | 0.3778 | 0.3778 |
| 02508257 | Jamp Amoxi Clav | 0.3778 | 0.3778 |
| 02536021 | Amoxicillin/Clav | 0.3778 | 0.3778 |